Ado-trastuzumab emtansine Intravenous and Afstyla recombinant
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Afstyla recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Aftera
- Ado-trastuzumab emtansine Intravenous-Aftertest Topical Pain Relief
- Ado-trastuzumab emtansine Intravenous-Agalsidase beta
- Ado-trastuzumab emtansine Intravenous-Agalsidase beta Intravenous
- Ado-trastuzumab emtansine Intravenous-Agenerase
- Ado-trastuzumab emtansine Intravenous-Aggrastat
- Afstyla recombinant-Adox Pak 2/100
- Afstyla recombinant-Adoxa
- Afstyla recombinant-Adoxa CK
- Afstyla recombinant-Adoxa Pak
- Afstyla recombinant-Adoxa Pak 1/100
- Afstyla recombinant-Adoxa Pak 1/150